Committed to improving the lives of all those affected by brain tumors.
We are strategically positioned to leverage our collective resources and knowledge to deliver the greatest impact to the brain tumor community. Through catalytic funding models, robust research collaborations, and a focused public policy agenda, we're driving systemic change to improve the pace of drug discovery and development.
From catalytic funding to intensive research collaborations to advocating for policies that impact those affected, we’re ensuring change on every level.